How A Pandemic Pushed The Gas Pedal On Patient Centricity In Clinical Trials
By Jennifer Duff, General Manager, Clinical Development Solutions

Scientific research is challenging. Scientific research on human beings is even more challenging. Factor in a global pandemic that altered nearly every form of human interaction, and you have the perfect storm to drive the clinical trial industry to change course. The good news — perhaps one of the few silver linings to emerge from the COVID-19 pandemic — is that this has largely been a change for the better. Clinical trials are quickly becoming more participant-friendly (and more provider-friendly) through the broader adoption of digital technologies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.